These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Measuring Subvisible Particles in Protein Formulations Using a Modified Light Obscuration Sensor with Improved Detection Capabilities. Ríos Quiroz A; Québatte G; Stump F; Finkler C; Huwyler J; Schmidt R; Mahler HC; Koulov AV; Adler M Anal Chem; 2015 Jun; 87(12):6119-24. PubMed ID: 26001042 [TBL] [Abstract][Full Text] [Related]
24. Analyzing subvisible particles in protein drug products: a comparison of dynamic light scattering (DLS) and resonant mass measurement (RMM). Panchal J; Kotarek J; Marszal E; Topp EM AAPS J; 2014 May; 16(3):440-51. PubMed ID: 24570341 [TBL] [Abstract][Full Text] [Related]
25. Extensive Chemical Modifications in the Primary Protein Structure of IgG1 Subvisible Particles Are Necessary for Breaking Immune Tolerance. Boll B; Bessa J; Folzer E; Ríos Quiroz A; Schmidt R; Bulau P; Finkler C; Mahler HC; Huwyler J; Iglesias A; Koulov AV Mol Pharm; 2017 Apr; 14(4):1292-1299. PubMed ID: 28206769 [TBL] [Abstract][Full Text] [Related]
26. The application of STEP-technology® for particle and protein dispersion detection studies in biopharmaceutical research. Gross-Rother J; Herrmann N; Blech M; Pinnapireddy SR; Garidel P; Bakowsky U Int J Pharm; 2018 May; 543(1-2):257-268. PubMed ID: 29604370 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of aggregate and silicone-oil counts in pre-filled siliconized syringes: An orthogonal study characterising the entire subvisible size range. Shah M; Rattray Z; Day K; Uddin S; Curtis R; van der Walle CF; Pluen A Int J Pharm; 2017 Mar; 519(1-2):58-66. PubMed ID: 28089934 [TBL] [Abstract][Full Text] [Related]
28. Subvisible Particle Analysis of 17 Monoclonal Antibodies Approved in China Using Flow Imaging and Light Obscuration. Guo S; Yu C; Guo X; Jia Z; Yu X; Yang Y; Guo L; Wang L J Pharm Sci; 2022 Apr; 111(4):1164-1171. PubMed ID: 34551350 [TBL] [Abstract][Full Text] [Related]
29. Quantitative laser diffraction method for the assessment of protein subvisible particles. Totoki S; Yamamoto G; Tsumoto K; Uchiyama S; Fukui K J Pharm Sci; 2015 Feb; 104(2):618-26. PubMed ID: 25449441 [TBL] [Abstract][Full Text] [Related]
30. Closing the Gap: Counting and Sizing of Particles Across Submicron Range by Flow Cytometry in Therapeutic Protein Products. Zhang L; Shi S; Antochshuk V J Pharm Sci; 2017 Nov; 106(11):3215-3221. PubMed ID: 28625725 [TBL] [Abstract][Full Text] [Related]
31. Radar chart array analysis to visualize effects of formulation variables on IgG1 particle formation as measured by multiple analytical techniques. Kalonia C; Kumru OS; Kim JH; Middaugh CR; Volkin DB J Pharm Sci; 2013 Dec; 102(12):4256-67. PubMed ID: 24122556 [TBL] [Abstract][Full Text] [Related]
32. Variance Between Different Light Obscuration and Flow Imaging Microscopy Instruments and the Impact of Instrument Calibration. Matter A; Koulov A; Singh S; Mahler HC; Reinisch H; Langer C; Zucol B; Mathaes R J Pharm Sci; 2019 Jul; 108(7):2397-2405. PubMed ID: 30844365 [TBL] [Abstract][Full Text] [Related]
33. Pharmaceutical feasibility of sub-visible particle analysis in parenterals with reduced volume light obscuration methods. Hawe A; Schaubhut F; Geidobler R; Wiggenhorn M; Friess W; Rast M; de Muynck C; Winter G Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1084-7. PubMed ID: 23454051 [TBL] [Abstract][Full Text] [Related]
34. Flow imaging microscopy for protein particle analysis--a comparative evaluation of four different analytical instruments. Zölls S; Weinbuch D; Wiggenhorn M; Winter G; Friess W; Jiskoot W; Hawe A AAPS J; 2013 Oct; 15(4):1200-11. PubMed ID: 23996547 [TBL] [Abstract][Full Text] [Related]
35. Evaluating the Role of the Air-Solution Interface on the Mechanism of Subvisible Particle Formation Caused by Mechanical Agitation for an IgG1 mAb. Ghazvini S; Kalonia C; Volkin DB; Dhar P J Pharm Sci; 2016 May; 105(5):1643-1656. PubMed ID: 27025981 [TBL] [Abstract][Full Text] [Related]
36. Application of different analytical methods for the characterization of non-spherical micro- and nanoparticles. Mathaes R; Winter G; Engert J; Besheer A Int J Pharm; 2013 Sep; 453(2):620-9. PubMed ID: 23727141 [TBL] [Abstract][Full Text] [Related]
37. Correcting the Relative Bias of Light Obscuration and Flow Imaging Particle Counters. Ripple DC; Hu Z Pharm Res; 2016 Mar; 33(3):653-72. PubMed ID: 26555667 [TBL] [Abstract][Full Text] [Related]
39. Submicron Protein Particle Characterization using Resistive Pulse Sensing and Conventional Light Scattering Based Approaches. Barnett GV; Perhacs JM; Das TK; Kar SR Pharm Res; 2018 Feb; 35(3):58. PubMed ID: 29423663 [TBL] [Abstract][Full Text] [Related]
40. Critical evaluation and guidance for using the Coulter method for counting subvisible particles in protein solutions. Barnard JG; Rhyner MN; Carpenter JF J Pharm Sci; 2012 Jan; 101(1):140-53. PubMed ID: 22109687 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]